ELIXER Secures New Investment at £2.2 Million Implied Valuation Ahead of Major UK Launch

Mildenhall, UK, August 14th, 2026, FinanceWire

ELIXER is a UK-based health and wellness company headquartered in Essex, has completed an equity investment involving the issue of new ordinary shares, implying a pre-money valuation of approximately £2.2 million as the company prepares for its next stage of commercial growth.

The transaction will be reflected in the company’s SH01 share allotment filing with Companies House, providing a public record of the newly issued shares.

The £2.2 million figure represents the valuation implied by the terms of the equity transaction. Alongside the completed equity investment, ELIXER is also in discussions regarding up to £100,000 in additional private growth capital, which, if completed, would support working capital, customer acquisition and wider business expansion.

ELIXER considers the additional capital an opportunity to strengthen working capital, support customer acquisition, expand business-to-business activity and provide additional runway during its next phase of development.

Founder Rowan Bradley said the company intends to maintain a relatively lean operating structure while using additional capital selectively. “The investment gives us the opportunity to properly test what we’ve built without dramatically increasing our fixed costs. We’ve spent a long time developing the products, manufacturing relationships, brand and infrastructure. The next stage is about proving that commercially.”

ELIXER ONE to Lead August Launch

At the centre of ELIXER’s next phase is ELIXER ONE, a new flagship product scheduled to launch as part of the company’s wider rollout at the end of August.

The company has not yet disclosed the full formulation ahead of launch. ELIXER says the product has been developed around a simpler approach to supplementation for adults over 30, an audience the company plans to make a central focus of its future product development.

ELIXER ONE will launch alongside the company’s presence in established supplement categories including NMN and creatine, with additional products planned as the wider range develops.

The company is also preparing redesigned digital platforms, including a dedicated e-commerce experience for ELIXER ONE.

UK Manufacturing and Quality Standards

ELIXER products are manufactured in the United Kingdom, with production taking place in a BRCGS AA+ certified facility.

BRCGS certification evaluates areas including manufacturing processes, quality-management systems, hygiene, traceability and operational controls across the production environment.

The company says this broader manufacturing framework forms an important part of its quality strategy alongside finished-product testing.

Bradley said: “Third-party testing can provide useful information about a finished product, while BRCGS looks at the wider systems and controls behind how that product is actually manufactured. We wanted that broader level of oversight to form part of the way ELIXER approaches quality.”

ELIXER is also aiming to keep as much of its wider supply and production chain within the UK as practical, with the company positioning British manufacturing and support for local businesses as part of its longer-term strategy.

National Launch and Brand Expansion

ELIXER’s upcoming August launch represents the next stage in the company’s broader commercial development as it moves from product and brand development into a more focused growth phase.

The company is preparing increased digital and media activity around the launch, with the campaign designed to strengthen awareness of the ELIXER brand and support the introduction of ELIXER ONE.

The business has also expanded its presence in sport through a partnership with Wivenhoe Town Football Club, with the club’s ground becoming the ELIXER Arena under a new sponsorship agreement.

The partnership is expected to include player content, digital campaigns and community-focused activity around the club, providing ELIXER with an additional platform for brand engagement as it expands.

ELIXER plans to continue investing selectively in its digital infrastructure, customer experience and product development as it evaluates demand and identifies the channels offering the strongest potential for sustainable growth.

Wider Health and Wellness Expansion

Beyond supplements, ELIXER is exploring future opportunities in the wider health and wellness market.

The business plans to develop premium at-home wellness services, including services aimed at athletes and high-performance clients as well as people seeking more convenient access to health and wellness support at home.

The company has not yet announced specific services or launch dates.

This expansion would represent a move beyond ELIXER’s current e-commerce model and potentially create an additional service-led arm of the business alongside its consumer product range.

Funding the Next Stage

The completed strategic equity investment and discussions around additional growth capital come as ELIXER moves from a prolonged product and brand-development period into a more commercially focused stage.

Over the next six months, ELIXER plans to focus on measuring customer-acquisition efficiency, subscription retention, direct-to-consumer performance and business-to-business demand as it scales the business following the investment.

Rather than committing significant capital immediately, ELIXER intends to retain a substantial proportion of any additional funding as working capital while increasing expenditure where individual sales channels demonstrate a measurable return.

The company’s growth model is expected to combine direct-to-consumer ecommerce, subscription revenue, wholesale distribution, strategic partnerships and future product development.

ELIXER’s wider launch is planned for 25 August, with ELIXER ONE forming the centrepiece of the company’s next phase.

About ELIXER

ELIXER is a UK-based health and wellness company headquartered in Essex. The company develops nutritional supplements and wellness products manufactured in the United Kingdom, with a focus on product development, manufacturing standards and direct-to-consumer growth.

Contact